About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
4 01, 2026

4 Supplements You Shouldn’t Take for Weight Loss

By |2026-01-04T05:28:17+02:00January 4, 2026|Dietary Supplements News, News|0 Comments


  • Some supplements for weight loss are unregulated, may be harmful and are not recommended.
  • Do not take green coffee bean extract, Garcinia cambogia, raspberry ketone or caffeine.
  • Work toward an energy deficit for weight loss with a healthy diet and daily exercise.

Losing weight is challenging, and many people turn to weight-loss supplements to help achieve their goals. Unfortunately, many supplements marketed for weight loss don’t do what they promise—and may even work against your goals. Not only are supplements expensive, but they are also unregulated, so you don’t always know what you’re getting. The best way to lose weight is to focus on a food-first approach, which means eating plenty of nutrient-dense foods and maintaining a slight calorie deficit over time. 

In this article, we get into some popular weight-loss supplements and why nutrition professionals don’t recommend them, plus helpful tips for healthy, sustainable weight loss. Knowing what to watch out for can help you make informed choices and prioritize strategies that actually support your health and weight-loss journey.

Green Coffee Bean Extract

If you’ve searched for supplements aiding weight loss, you’ve likely come across green coffee bean extract. Quite simply, this supplement is derived from the coffee plant’s seeds, which are green before roasting. “[Green coffee bean extract] has chlorogenic acid, a coffee compound that can supposedly decrease fat absorption and speed up metabolism,” says Danielle VenHuizen, M.S., RDN. She adds that these claims are mostly unwarranted. 

Only a few human trials have examined the effectiveness of green coffee bean extract on weight loss. These trials had poor study design and showed mixed results. While one study found that green coffee extract may help reduce weight and body mass index, there wasn’t a significant effect on body fat percentage, meaning that the mass lost could come from water or muscle.

Body mass index (BMI) is a flawed measure that’s often used in healthcare to determine a person’s body weight category, and therefore, chronic disease risk. However, it has limitations and does not account for individual factors that influence one’s health status, such as body composition, ethnicity, race, sex and age. This is why it shouldn’t be used as a comprehensive measure of someone’s health and can be a source of body size stigma and bias.

“Additionally, in my clinical experience, I have yet to meet a client who has lost weight by using green coffee bean extract,” says VenHuizen. Lastly, there isn’t much information on the safety of green coffee bean extract, so buyers beware. 

Garcinia Cambogia

Garcinia cambogia is a fruit with ​​hydroxycitric acid (HCA), a compound thought to reduce fat production in the body and suppress appetite. “Studies seem to indicate that some of these claims might be true, but unfortunately, the benefits are modest, and the research is conflicting,” says VenHuizen. One study states that there are only a small number of studies on Garcinia cambogia, and the methodology is poor, meaning that these results shouldn’t be trusted.

Even more alarming, “several studies have reported liver issues with long-term use of this supplement,” says VenHuizen. This is another pretty convincing reason to avoid adding this supplement to your weight-loss regimen. 

Raspberry Ketone

Raspberry ketone is a compound found in the raspberry fruit. Small test-tube and animal studies suggest it may suppress the buildup of fat in the body, but the results are extremely limited. There has only been one human study on the effects of raspberry ketone on weight loss. The participants took the supplement for eight weeks while also following a calorie-restricted diet. The raspberry ketone supplement was combined with caffeine, bitter orange, ginger, garlic, cayenne, L-theanine, pepper extract, B vitamins and chromium. 

The 45 participants who finished the study lost weight, but it’s impossible to know if it was due to the raspberry ketone blend or the calorie deficit. In short, there isn’t enough evidence to support raspberry ketone for weight loss, so save your money. Instead, we recommend snacking on some raspberries, which have several health benefits, including filling fiber and inflammation-fighting anthocyanins.

Caffeine

The most recognizable supplement on this list, caffeine is a compound that stimulates the nervous system. It’s naturally present in tea, coffee and chocolate, as well as in herbal supplements like guarana. Caffeine increases thermogenesis, the body’s natural production of heat. During this process, the body burns extra calories. 

Research suggests caffeine can help with weight loss, but a large dose is necessary to create a response. One study concluded that more than 3 milligrams of caffeine per kilogram of body weight is necessary to stimulate the breakdown of fat. For a 150-pound person, that’s 200 mg of caffeine, or two cups of coffee. 

It is recommended to cap caffeine consumption 400 mg daily for safety, but everyone has a different tolerance level. People sensitive to caffeine may experience symptoms like nervousness, jitters, heart racing and headaches, among others. 

Although caffeine may increase fat loss, it’s not the best way to lose weight, especially because supplements with caffeine may contain more than that, plus other stimulants. That said, caffeine from natural sources like coffee is the safest way to consume caffeine. So, feel free to include a cup of coffee or tea in your day for an energy boost, but don’t expect it to affect your weight too much. 

Tips for Healthy Weight Loss 

Although they may not be quick or flashy, the most effective tools for losing weight are good old-fashioned healthy eating and exercise. VenHuizen recommends increasing fiber-rich fruits and vegetables and healthy fats in the diet. “These foods naturally increase satiety and provide anti-inflammatory benefits that may aid in weight loss,” says VenHuizen. “And unlike supplements, studies on fruit and vegetable intake show that these foods improve weight-loss efforts,” she adds. 

In addition, “Trying to stay moderately active throughout the day, especially for people who work sedentary desk jobs, can help with weight loss,” says Madeleine Putzi, M.S., RDN. She recommends getting up and walking around once per hour to increase your total amount of steps for the day, which is an easy and non-taxing way to increase your daily calorie burn. 

Putzi also suggests investing in a standing desk and/or a walking pad if possible. “If you walk for 10 minutes at 3 miles per hour, you will hit around 1,000 steps. Do that every hour, and that’s an easy 8,000 steps by the end of your workday,” says Putzi.

Our Expert Take

Weight-loss supplements are usually not worth the expensive price tag. If a supplement promises to “magically burn fat or flatten your belly,” chances are it’s not the miracle that’s promised on the bottle. A food and exercise approach to weight loss is the most effective way to reach your weight-loss goals in a sustainable way.



Source link

4 01, 2026

Cardano Price Prediction: ADA Faces Trendline Rejection Near $0.35 as Bearish Momentum Builds

By |2026-01-04T05:19:38+02:00January 4, 2026|Crypto News, News|0 Comments

Cardano price is struggling below $0.35 trendline resistance as bearish momentum persists, with traders watching the $0.30–$0.35 support zone for signs of a potential base or further downside.

Cardano price is back under pressure as the price continues to stall below the descending trendline resistance near $0.35. Despite several short-lived bounces, buyers have yet to show conviction, leaving the near-term structure skewed to the downside.

This hesitation comes as ADA trades near the lower end of its multi-month range following a prolonged drawdown from its 2021 high. While longer-term support levels are beginning to attract attention, the broader technical picture suggests that any recovery attempts remain vulnerable unless key resistance is reclaimed.

Trendline Resistance Signals Short-Term Risk

On the short-term chart, analyst Kamran Asghar highlighted that ADA is facing descending trendline resistance, with bearish pressure building near the $0.35 area. His analysis suggests that repeated rejection from this trendline increases the likelihood of downside continuation if buyers fail to regain control.

Cardano’s ADA continues to face selling pressure near descending trendline resistance around $0.35, reinforcing short-term downside risk as lower highs persist. Source: Kamran Asghar via X

The chart shows ADA printing lower highs, a classic sign of weakening momentum. As long as price remains capped below the trendline, rallies risk being sold into rather than developing into sustained recoveries. In this context, rejection at current levels could expose ADA to renewed tests of lower support zones. This setup keeps short-term bias tilted towards caution, especially as broader market conditions remain mixed.

Cardano Daily Structure Remains Bearish

Further reinforcing the bearish outlook, data shared by CardanoMentor shows ADA trading well below its major daily moving averages. The chart reflects a prolonged downtrend, with price unable to reclaim the 50-day or 200-day averages, a condition typically associated with bearish continuation.

Momentum indicators on the daily timeframe remain weak, suggesting limited buying strength despite occasional relief bounces. As long as ADA remains below these averages, downside risk persists, and any upside attempts may struggle to gain momentum.

Cardano Price Prediction: ADA Faces Trendline Rejection Near alt=

ADA continues to trade below key daily moving averages, signaling sustained bearish structure and limited upside momentum. Source: CardanoMentor via X

Loss of Top-10 Market Cap Shows Weakness

Adding to the pressure, analyst Yazan pointed out that Cardano is no longer a top-10 cryptocurrency by market capitalization, a development that reflects prolonged underperformance relative to peers.

While market cap rankings alone do not determine future price direction, they often influence sentiment and capital rotation. ADA’s slide down the rankings underscores the lack of sustained demand and highlights the challenges facing the asset in regaining investor confidence in the short term. This sentiment backdrop aligns with the current technical weakness seen on the charts.

Loss of Top-10 Market Cap Shows Weakness

ADA slips out of the top-10 cryptocurrencies by market capitalization, highlighting prolonged underperformance and weak investor demand. Source: Yazan via X

Bulls Hopeful of Holding Weekly Support at $0.35-$0.30

On the higher timeframe, Cardano is trading inside a well-defined long-term support range between $0.30 and $0.35, a zone that has repeatedly acted as a demand base across multiple market cycles. This region coincides with prior consolidation from late 2020 and early 2023, making it technically significant rather than arbitrary.

Analyst Hardy highlighted this area as a structural accumulation zone, noting that price is currently compressing near the lower end of its multi-year range. His chart shows ADA repeatedly finding support above the $0.30 handle, suggesting that sellers are losing momentum as price revisits historically defended levels.

Bulls Hopeful of Holding Weekly Support at $0.35-$0.30

ADA compresses within a long-term support range between $0.30 and $0.35, an area analysts view as a potential accumulation zone if weekly support continues to hold. Source: Hardy via X

From a technical standpoint, a sustained hold above $0.30 keeps the broader base-building structure intact. A clean break below this level, however, would invalidate the accumulation thesis and expose ADA to deeper downside towards the $0.25 to $0.22 region, where the next major historical demand zone sits.

On the upside, the first meaningful sign of recovery would be a reclaim of the $0.38 to $0.40 resistance band, followed by acceptance above the $0.45 level.

Cardano Price Analysis

Cardano remains under pressure below trendline resistance near $0.35, keeping the short-term structure tilted bearish. Repeated rejections from this level suggest sellers are still in control, and as long as ADA Cardano price below this zone, upside attempts are likely to remain capped. On the downside, immediate support sits at $0.33 to $0.32, with a breakdown opening the door towards $0.30, a key psychological and technical level. A daily close below $0.30 would expose deeper downside risk towards $0.28 to $0.27.

For any recovery to gain momentum, ADA must reclaim $0.35 and then push above the $0.38 to $0.40 resistance band, which marks prior breakdown support and overhead supply. A sustained move above this region would improve momentum and shift focus towards $0.44–$0.46. Until those levels are reclaimed, price action remains corrective, with market watchers likely watching reactions around $0.33 and $0.30 for direction.

Final Thoughts: Is Cardano Near a Long-Term Base?

Cardano’s short-term outlook remains cautious, with bearish structure and resistance overhead continuing to cap price. Trendline rejection and weak momentum suggest that downside risks are still present in the near term.

However, longer-term charts are signaling a different story. The presence of a historically significant accumulation zone suggests that ADA may be transitioning from distribution into base-building. Whether this zone ultimately marks a durable bottom will depend on how Cardano price behaves here.



Source link

4 01, 2026

The truth about the ‘liquid gold’ supplement that claims to boost your immunity

By |2026-01-04T03:26:47+02:00January 4, 2026|Dietary Supplements News, News|0 Comments


Colostrum is often called “liquid gold” by lactation specialists, midwives and infant-health researchers. It’s the early milk produced in the first days after childbirth: thick, yellow and rich in antibodies, proteins and nutrients.

Newborn babies benefit greatly from it because their immune systems are not yet fully developed and their stomachs can only hold very small amounts. For babies, there’s no debate: colostrum is incredibly beneficial.

But some wellness brands are marketing colostrum to adults. Kourtney Kardashian Barker’s Lemme range sells it as sweet gummies, a sugar-free liquid supplement and creamer.

The appeal is easy to understand. Colostrum has a powerful reputation in infant health. If it protects newborns, many assume it must offer something extraordinary for adults too – but does it?

Babies and adults have very different nutritional needs. A newborn’s stomach holds only a few millilitres, and their immune system is immature. Colostrum provides highly concentrated immune and nutritional factors that the baby needs in its first days of life.

Kourtney Kardashian Barker’s Lemme range sells colostrum as sweet gummies, a sugar-free liquid supplement and creamer (Getty)

Adults, by contrast, have fully developed digestive and immune systems and can obtain nutrients from a varied diet. An adult stomach holds around one to one-and-a-half litres and expands further after eating. What is essential for a baby is not automatically useful or necessary for an adult body.

While colostrum has undeniable benefits in early life, the versions sold to adults are processed, flavoured and taken in much smaller amounts. That’s why it’s important to look closely at what these products contain and what their marketing suggests they can do.

Colostrum-based supplements are often promoted using persuasive wellness language and health-related suggestions, but scientific evidence for their effectiveness in adults remains limited, early and often based on small studies involving specific groups rather than healthy people. Here’s a closer look at the ideas behind some of these marketing messages and what research actually tells us.

Gut health, digestion and reduced bloating

Some small studies suggest that bovine colostrum might reduce temporary increases in intestinal permeability, sometimes called “leaky gut”, where the lining of the intestine becomes less effective at keeping out bacteria and toxins. These changes can occur after intense exercise or when taking non-steroidal anti-inflammatory medicines, drugs that can irritate the stomach and gut lining.

However, these studies involved only a small number of participants in specific contexts, not healthy adults in everyday life. The findings are considered preliminary and would require larger, well-designed clinical trials before any conclusions could be drawn about general digestive benefits.

The truth about the ‘liquid gold’ supplement that claims to boost your immunity

Some small studies suggest that bovine colostrum might reduce temporary increases in intestinal permeability (Getty/iStock)

The prebiotic fibres inulin and xylooligosaccharides, sometimes added to supplements, are much better studied. Inulin has been shown to increase levels of beneficial gut bacteria such as bifidobacteria, while xylooligosaccharides have been linked to greater bacterial diversity and small improvements in markers related to bowel health, obesity and type 2 diabetes in early research.

But these fibres are not unique to colostrum-based products. They also occur naturally in foods such as onions, garlic, leeks, bananas and chicory root and are widely available as standalone fibre supplements.

Immune system support

Colostrum helps newborns develop immunity by providing antibodies at a time when their immune systems are still forming. This does not mean that taking colostrum will strengthen a healthy adult’s immune system.

The idea of “boosting” immunity – a phrase used in promotional material for Kardashian Barker’s Lemme colostrum supplements – is common in wellness marketing, but it can be misleading.

A healthy immune system doesn’t usually need boosting, and an overactive one can cause harm by attacking the body’s own tissues, as happens in autoimmune conditions such as type 1 diabetes or rheumatoid arthritis.

About the author

Rachel Woods is a Senior Lecturer in Physiology at the University of Lincoln.

This article was first published by The Conversation and is republished under a Creative Commons licence. Read the original article.

Some research has explored the potential of bovine colostrum in specific conditions, such as ulcerative colitis and travellers’ diarrhoea. But these studies are small, focus on people who are already unwell and cannot be generalised to the wider population. Anyone with health concerns should seek medical advice before taking any supplement.

In Lemme’s products, references to immune support appear to rely primarily on vitamin D. Vitamin D does help regulate the immune system and supports bone health, and low levels are common in winter or in people with limited sunlight exposure. However, vitamin D is inexpensive and widely available as a standalone supplement.

“Full body wellness”

This is a broad phrase without a specific scientific definition. On the Lemme website, the company states that vitamin D supports healthy bones and teeth, which is accurate, but that benefit is not unique to its colostrum products.

“Glowing skin”

This phrase has appeared in some advertising coverage but not on the official product page. “Glowing skin” has no clinical definition and no standard method of measurement. There’s currently no evidence that colostrum, or any of the ingredients in these supplements, produces this effect.

How language influences trust

Lemme’s website includes the standard disclaimer found on most dietary supplements, stating that the products are not intended to diagnose, treat, cure or prevent disease.

The brand also describes its ingredients as “clinically studied.” This is not the same as “clinically proven.” The phrase typically means that an ingredient has been tested in some form of study, but it does not indicate whether the results were positive, significant or relevant to human health.

Research shows that consumers often confuse these terms. It sounds scientific, but does not demonstrate proven efficacy.

Colostrum is extraordinary for newborns. Nature designed it to protect babies during their most vulnerable days. For adults, however, there is no strong evidence from large, well-designed trials that colostrum supplements improve skin, digestion or immunity in healthy individuals. Some ingredients in these products may show potential in specific medical conditions, but that is not the same as demonstrating general wellness effects.

Colostrum supplements primarily market the idea of something pure, powerful and natural. At present, the science does not fully support these suggestions.



Source link

4 01, 2026

Solana Price Prediction: Solana Holds $120 Support as Momentum Hints at a Trend Reversal

By |2026-01-04T03:18:35+02:00January 4, 2026|Crypto News, News|0 Comments

Solana price is consolidating above key support levels as price tightens, with traders watching closely for signs of a potential upside breakout.

Solana price has been moving sideways for a while now, but the range is starting to tighten. Price is holding above key support, yet every push higher keeps getting sold. With momentum cooling and the chart compressing, Solana Price Prediction is back in focus as market watchers wait to see which side finally takes control.

Short-Term Structure Remains Capped Below Descending Channel Resistance

On the daily timeframe, Solana is attempting to break past the descending channel, a structure that has defined price action since the post-ATH correction. However, according to Nehal, as long as SOL remains below the upper channel resistance near $155–$160, upside moves should still be treated as corrective rather than impulsive.

Solana price trades below descending channel resistance near $155–$160, keeping the short-term structure capped despite repeated support holds. Source: Nehal via X

Repeated rejections from this zone reinforce it as the key level bulls must reclaim to signal a shift in trend. Failure to break above this area keeps downside risk active towards the $120–$115 support region, which has acted as a short-term demand zone during recent pullbacks. A daily close above $160 would be the first structural sign that sellers are losing control.

RSI and Momentum Echo Historical Oversold Conditions

Momentum indicators provide important context to the current consolidation. Immortal highlighted that during Solana’s capitulation low near $8, RSI printed around 28, marking extreme oversold conditions. In the most recent pullback, RSI once again dipped close to 30, suggesting selling pressure may be nearing exhaustion rather than accelerating.

Solana Price Prediction: Solana Holds 0 Support as Momentum Hints at a Trend Reversal

Solana’s RSI drops back toward the 30 level, mirroring historically oversold conditions that previously marked selling exhaustion. Source: Immortal via X

Adding to this, That’s My Quant noted that Solana has been consolidating for over a year, with RSI spending extended time near historically undervalued zones. This behavior typically aligns more with accumulation phases than with early-stage bear market expansions, though confirmation is still required through price.

RSI and Momentum Echo Historical Oversold Conditions

Solana continues a year-long consolidation, with RSI lingering near historically undervalued zones that often align with accumulation phases. Source: That’s My Quant via X

Weekly Support Zone Keeps Long-Term Bulls Engaged

Zooming out to the higher timeframe, Solana price is currently holding a major weekly support band between $110 and $125, an area that previously acted as a base before large upside expansions. Long-term participants are closely watching this zone, as sustained acceptance above it keeps the broader structure neutral-to-constructive rather than decisively bearish.

From a market structure perspective, as long as SOL does not lose the $110 weekly support, the probability of continued range development remains higher than that of a full trend breakdown. However, reclaiming $160, followed by a move through the $180–$200 resistance cluster, would be necessary to re-establish a bullish higher-high sequence.

On-Chain Strength Adds a Contrasting Narrative

While price remains technically constrained, on-chain data paints a more constructive outlook. Crypto Chiefs highlighted that Solana currently leads application revenue among major chains, capturing a significant share relative to Ethereum and others. This divergence between on-chain strength and price action often appears during late consolidation phases, though timing remains uncertain.

On-Chain Strength Adds a Contrasting Narrative

Solana leads application revenue among major blockchains, highlighting strong on-chain activity despite price remaining range-bound. Source: Crypto Chiefs via X

Technical Structure Shaping Solana’s Next Move

Several technical signals are defining Solana’s current consolidation phase. On the daily chart, Solana price is trading within a descending channel, with price repeatedly forming higher lows near the lower boundary, suggesting selling pressure is slowing.

Technical Structure Shaping Solana’s Next Move

Solana current price is $132.73, up 5.42% in the last 24 hours. Source: Brave New Coin

This compression indicates a market waiting for direction rather than trending impulsively.

Key levels to watch:

  • Channel resistance: $155–$160
  • Near-term upside zone: $180–$200 if a daily close above $160 holds
  • Primary support: $120–$115
  • Major weekly support: $110–$125

The structure remains neutral-to-bullish as long as SOL holds above weekly support. A clean breakout above the upper channel, ideally accompanied by rising volume, would signal a shift from corrective price action into trend recovery. Until then, rallies remain vulnerable to rejection, keeping SOL range-bound.

Momentum indicators such as RSI hovering near historically oversold zones further reinforce the idea that this is a compression and basing phase, not a momentum-driven breakdown.

Final Thoughts: Can Solana Price Reclaim Bullish Momentum?

Solana price is not in a confirmed uptrend yet, but it is also not breaking down. The market is compressing between weekly support at $110 to $125 and channel resistance at $155–$160, with momentum indicators suggesting downside pressure is slowing rather than accelerating.

A clean daily and weekly reclaim above $160 would significantly improve the bullish case and open Solana price prediction towards $180 to $200. Until then, SOL remains in a technically neutral consolidation phase, where patience and confirmation matter more than anticipation.



Source link

4 01, 2026

Quiet Strength, Cautious Optimism Behind Japan’s Tea Champion

By |2026-01-04T01:25:34+02:00January 4, 2026|Dietary Supplements News, News|0 Comments


Ito En’s share price has drifted modestly higher over the past week while holding a solid year?on?year gain. Behind the calm chart is a company quietly refining its green tea dominance, defending margins against cost pressures and drawing measured interest from analysts who see limited downside but only selective upside.

Investors hunting for fireworks in Japanese consumer stocks will not find a spectacle in Ito En right now, but the market’s message is quietly constructive. The tea and beverage specialist has edged up over the past several sessions, extending a steady medium term advance while avoiding the sharp swings seen elsewhere in the food and drink space. The tone around the stock is neither euphoric nor fearful. Instead, Ito En sits in that intriguing middle ground where resilient fundamentals and modest valuation upside coexist with very real margin and FX risks.

One-Year Investment Performance

A year ago, buying Ito En looked like a conservative bet on Japanese consumption rather than a high octane growth play. That caution has been rewarded more than punished. Based on exchange data compiled from Yahoo Finance and other quote services, Ito En’s stock closed roughly 15 to 20 percent lower one year ago compared with its latest close. The exact figures vary slightly across providers, but the directional message is clear: the past twelve months have delivered a solid, mid teens percentage gain for patient shareholders.

What does that mean in real money terms? A hypothetical investor who had committed the equivalent of 10,000 units of local currency to Ito En a year ago would now sit on a position worth roughly 11,500 to 12,000, before dividends and trading costs. That is not the kind of windfall that turns heads on social media, yet in the context of a choppy global consumer landscape and lingering inflation in input costs, it reflects impressive capital preservation with a respectable kicker. The ride has not been entirely smooth, with pullbacks during broader Japanese equity corrections, but the long term trajectory still tilts decisively upward.

For investors who stepped in near last year’s lows, the performance looks even better when viewed against Ito En’s 52 week range. The share price currently trades close to the upper half of that band, comfortably above the 52 week low and below but not far from the 52 week high. That position within the range suggests that while the easy money from the recovery phase may already be made, the stock has avoided the kind of frothy overextension that often precedes sharp reversals.

Recent Catalysts and News

In terms of fresh headlines, the past several days have been relatively subdued for Ito En. A targeted search across major business outlets and Japanese market coverage turns up no blockbuster announcements such as transformative acquisitions or radical management changes in the very recent past. Instead, the narrative revolves around incremental developments: ongoing product refreshes in the ready to drink green tea segment, marketing efforts around functional beverages and continued discipline in cost management amid elevated raw material and logistics expenses.

Earlier this week, local coverage and industry commentary focused more on sector level trends than on Ito En specifically. Rising attention to healthier, low sugar drinks and sustained interest in green tea based beverages continues to favor Ito En’s core franchise. The company appears to be leaning into this tailwind with product line extensions and packaging innovations rather than radical repositioning. At the same time, commentary from Japanese equity strategists highlights that food and beverage names such as Ito En are benefiting from investors rotating toward defensive growth while keeping a close eye on yen fluctuations that can affect imported ingredient costs.

Looking slightly beyond the very latest headlines and into the recent quarter, Ito En’s results have generally reinforced this picture of measured momentum. Revenue growth has been supported by both volume and pricing, though management has acknowledged that passing through higher costs without denting demand remains a delicate balancing act. There has been no sign of a dramatic pivot away from the core tea and beverage business, which remains the economic engine, but rather a continued emphasis on deepening distribution, optimizing vending machine networks and fine tuning the product mix for profitability.

Wall Street Verdict & Price Targets

When it comes to external opinions, Ito En does not command the same level of global analyst coverage as mega cap tech or automotive names, yet several major houses keep the stock on their radar. A search across international broker commentary from providers such as Morgan Stanley, UBS and local Japanese brokerages indicates a broadly neutral to moderately positive stance within the last month. The prevailing rating cluster sits around Hold with select Buy recommendations that frame Ito En as a quality defensive play rather than a high growth story.

Recent notes from analysts, as summarized in regional financial media, point to price targets that imply limited but not negligible upside from the current quote. Typical target ranges hover in the mid single digit to low double digit percentage above the latest trading level. Morgan Stanley and UBS, for example, emphasize Ito En’s strong brand equity and stable cash generation, but temper their enthusiasm with references to cost inflation, domestic market saturation and the relatively slow pace of overseas expansion. There is little appetite to slap a Sell label on the stock, yet these institutions also stop short of championing it as a must own outperformer.

This consensus leaves investors with a clear message. At current prices, Wall Street and Tokyo based strategists broadly regard Ito En as fairly valued to slightly undervalued. The stock’s 90 day trend, which shows a gentle upward slope rather than a sharp spike, reinforces this notion of gradual appreciation rather than speculative frenzy. For portfolio builders, that makes Ito En a candidate for the core defensive sleeve more than a tactical trading vehicle.

Future Prospects and Strategy

Underneath the share price sits a business model that is remarkably simple to describe yet difficult to replicate. Ito En is, at its heart, a beverages company built on Japanese tea culture. It has turned green tea and related drinks into a scalable, highly recognizable product family across supermarkets, convenience stores and vending machines. The company also extends into tea leaves and allied products, but the ready to drink segment is the centerpiece of both revenue and investor attention.

Looking ahead to the coming months, several factors will shape Ito En’s trajectory. First, input cost dynamics matter. Any easing in packaging and logistics expenses would flow quickly into margins, especially if the company can hold the pricing gains it has already pushed through. Second, currency moves remain a double edged sword, influencing both imported costs and the translation of any overseas earnings. Third, domestic demand for healthier beverages provides a structural tailwind, but the pace and profitability of international expansion will determine whether Ito En can accelerate growth beyond its home market baseline.

The technical picture complements this fundamental story. The five day performance shows a modest gain, reflecting gentle buying interest rather than a speculative surge, while the broader 90 day trend captures a slow grind higher from previous consolidation levels. Volatility has been contained, suggesting that short term traders are not dominating the shareholder register. If the company can deliver another stable earnings print and demonstrate continued discipline on costs, the stock appears well placed to continue this steady ascent, albeit without dramatic re rating.

For investors, the key question is simple: is a high quality, defensive Japanese beverage champion with mid teens one year gains and a calm chart worth holding at current levels? The answer likely depends on portfolio context. For those seeking explosive growth, Ito En may look too measured. For those seeking resilient cash flows, brand strength and a relatively predictable earnings stream in a turbulent world, the market’s current, cautiously bullish stance on Ito En might feel exactly right.



Source link

3 01, 2026

4 Potential Side Effects of Creatine You Should Know About

By |2026-01-03T23:24:36+02:00January 3, 2026|Dietary Supplements News, News|0 Comments


Creatine is one of the most popular supplements for improved exercise and physical performance. Possible side effects caused by creatine include weight gain, nausea, diarrhea, muscle cramps, and heat intolerance.

The most commonly reported side effect of creatine is weight gain. This increase in weight happens because creatine brings water into your muscles. The increase in water (also known as water retention) can make it seem like you have gained weight.

Creatine is “osmotically active”, meaning when you have creatine in your muscle cells, it brings water with it. This can cause water retention and lead to weight gain. Creatine may also help increase your muscle mass, potentially leading to changes in your weight. However, you are likely using creatine for this muscle increase.

Any signs of weight gain should go away after the first 1 to 2 weeks of taking creatine. Water retention is more likely if you are taking a “loading” dose of creatine. A loading dose is a higher dose of creatine, taken to maximize the amount of creatine stored in the body.

The usual loading dose is 20 to 25 grams daily for 5 to 7 days. The typical daily maintenance dose of creatine (3 to 5 grams per day) is less likely to cause water retention.

Nausea and diarrhea are two gastrointestinal (GI) side effects reported with creatine use. These are reported more commonly during the phase of creatine loading.

Nausea is likely caused by the large amount of water and creatine ingested, while diarrhea is likely caused by creatine pulling water into your intestines.

Muscle cramps and muscle stiffness are also reported side effects of creatine. Many studies reporting this were conducted in athletes, who also used various supplements and exceeded the recommended dose of creatine.

Researchers initially thought that the cramping was caused by dehydration. However, studies have not shown that this is true. Some studies have even shown that creatine helps to relieve muscle cramps.

More research is needed on the topic to understand how creatine affects the muscles.

When taking creatine, you may feel overheated, especially in warm environments. This feeling (also called heat intolerance) is thought to be caused by the supplement.

However, studies are conflicting on if this is true. It is more likely that heat intolerance is caused by exercise or physical activity. More research is needed on this side effect.

Though creatine side effects are not dangerous or common, they can be bothersome. To lower your risk for these side effects, consider doing these things:

  • Stay hydrated: Keeping your body hydrated lowers your risk of side effects. Being hydrated also causes you to urinate (pee) more, which helps eliminate excess fluid in your body.
  • Stretch: Relieve muscle cramps and stiffness by stretching regularly before and after exercise. Stretching carefully while you have a muscle cramp or stiffness can also help with the uncomfortable feeling.
  • Eat less salt: Excessive salt intake can increase your risk of water retention. If you notice that you are retaining more water than usual, consider reducing your salt intake.

Consult a healthcare provider if you have any questions or concerns about creatine side effects.



Source link

3 01, 2026

XRP Price Prediction: Can XRP Recover from Below $2 as MUTM Rises as the Best Crypto to Buy 

By |2026-01-03T23:16:38+02:00January 3, 2026|Crypto News, News|0 Comments

The current market price for XRP is below the $2 mark, and the sentiment remains weak, with investors waiting for confirmation of a possible long-term recovery. The market size and maturity of XRP imply a muted rally, which may have to await a positive sentiment drift in the overall market. Conversely, the spotlight has been shifting towards an early-stage DeFi project, Mutuum Finance (MUTM), which is currently in the presale phase. 

MUTM is different from XRP, with its strong DeFi focus, an early-stage advantage and rapidly growing holder-base. In no time, the new crypto has surpassed 18660 token holders and has quickly become among the best cryptos to buy for early adopters.

XRP Price Prediction

XRP’s 2025 was a rollercoaster, with regulatory victories such as the SEC settlement, listing of US-based spot ETFs, and increased engagement with Ripple partners, yet its price declined significantly by 50% from $3.66 to $1.58, failing to reach $5. As XRP embarks on a new year in 2026, technical analysis presents a potential for additional decline if current support levels are broken, although ongoing ETF investments combined with regulatory support might establish a basis for a recovery. While there exists a recovery potential in XRP, its large market and relatively slower pace limits how high it could go compared to Mutuum Finance, which has been termed as the next crypto to explode.

Mutuum Finance (MUTM)

Mutuum Finance has moved into Presale Phase 7, where the tokens are priced at $0.04. However, this phase is filling up quickly, and as such, the price will go to $0.045 in Presale Phase 8. So far, the presale event has raised $19.6 million. 

The current token value is 300% higher than Presale Phase 1, at $0.04, and with a projected 50x rally from the current levels, MUTM could touch $2 by the end of the year. In this scenario, a small bet of $500 today could swell to $25,000. Such a growth projection within the first few months makes MUTM the best crypto to buy now and a must-hold in the next bull run. Early investors looking for the next crypto to explode see this as a no-brainer bet.

XRP Price Prediction: Can XRP Recover from Below  as MUTM Rises as the Best Crypto to Buy 

Next-Generation DeFi Platform

Mutuum Finance is an open lending and borrowing platform that facilitates the creation of yields, lending of assets, and effortless borrowing. The design and functionality of the platform are focused on the principles of secure returns on investment. The platform uses a two-model approach to lending, which involves Peer-to-Contract (P2C) and Peer-to-Peer (P2P) lending.

Peer-to-Contract relies on smart contracts for automating loans, which adjust interest rates according to market trends. In this way, there is predictability and stability in borrowing and lending. On the other hand, Peer-to-Peer lending facilitates direct transactions between lenders and those seeking loans, thereby cutting off third parties. 

Say for instance an investor has $7500 ETH lying in their wallet. If ETH doubles in price over the next one year, this investment will only grow into $15,000. On the other hand, if they choose to deposit it in MUTM’s lending pools, it will deliver an 8-12% APY on top of this growth. The initial $7500 will deliver an extra $900 and the investor does not need to sell their ETH. 

Halborn Security Audit & Sepolia Testnet Launch

The lending & borrowing contracts of Mutuum Finance have been audited for security by Halborn Security, and all suggested patches have been successfully implemented. This adds an extra layer of security to the protocol, ensuring that investors have peace of mind, knowing that their assets are safe. The audit process is over, and the V1 protocol is now set to launch on the Sepolia testnet.

Testnet will consist of a number of key functionalities, which will include Liquidity Pools related to lending and borrowing, mtTokens that will indicate the deposits made as well as the accumulated interest accrued from these deposits, and an Automated Liquidator Bot. This will enable users to test functionality of the system. First, it will focus on ETH and USDT, which will be its key digital currencies to work with when it comes to lending and borrowing. This, however, will soon be upgraded to enable compatibility with other tokens. 

Although XRP is currently trading below $2 with limited potential to go higher due to market maturity, a promising opportunity for early investors lies in the Presale Phase 7 token price of $0.04 in Mutuum Finance (MUTM). For investors asking which is the best crypto to buy, MUTM sets itself apart. Its P2P + P2C lending model appeals to all types of DeFi users and their respective risk profiles. The project will soon go live on the Sepolia tesnet where users will get to test its features. This sets it apart from most other projects that launch with no working tools, but empty promises. As 2026 kicks off, analysts see this as the next crypto to explode. 

For more information about Mutuum Finance (MUTM) visit the links below:

Website: https://mutuum.com/

Linktree: https://linktr.ee/mutuumfinance

Source link

3 01, 2026

Japanese Yen Outlook for 2026: Bulls Eye 158–162 as Yields Stay Elevated

By |2026-01-03T21:29:31+02:00January 3, 2026|Forex News, News|0 Comments

USD/JPY Forecast for 2026

So now that we have the backdrop here, where do we go in 2026? What’s the outlook for all of the key components?

The first one, of course, is the Federal Reserve’s gradual easing, but yields will remain elevated. And I think the keyword here is gradual. I don’t think the Fed’s going to panic, at least not anytime soon. The Bank of Japan may continue to creep towards normalization, but there’s a big question with that. And of course, the yield differentials will remain strongly positive for the US dollar.

Intervention risk is by the Japanese, but I don’t think that’s likely. Inflation in Japan should moderate, limiting some of the Bank of Japan’s urgency. And a short-term driver for this pair, which I think is secondary to yields, will be the risk sentiment of global traders. That’s almost always the case with this pair anyway.

Bullish Scenario

So, let’s lay out both scenarios. The bullish case, which is pretty much my base case, certainly the higher probability, is that yields in the United States remain relatively high despite rate cuts. We’ve already seen that play out. Normalization in Japan remains incremental at best and probably fragile. Global capital continues to favor US dollar assets. I see that in other markets, not just this one, and the carry trade demand remains strong. This is a market that I think continues to grind higher with short-term sharp reversals. In other words, it’s going to behave much as it has over the last three or four months.

Bearish Scenario

The bearish case scenario, which I think is about a 30% chance at this point, is that the U.S. weakens or, for that matter, growth slows sharply, and it compresses yields. I don’t see that happening. I think it’s a very low likelihood. The Bank of Japan accelerates normalization unexpectedly. I think there’s almost no real risk of that. But if we do get a sustained risk-off environment, that does favor the yen. So that is probably the most likely of scenarios that trigger a bearish move.

Coordinated intervention has happened in the past when the yen starts to get too strong or too weak, but I don’t think we’re anywhere near that. The United States dollar would correct lower against the Japanese yen, but likely to remain within a bullish structure longer term. So, I think the bearish case is at best going to be a quarter of the year.

We may see something like that, but overall, I still think without some type of unforeseen external circumstance, the base case scenario is still bullish. Yield differentials, I believe, will remain the primary driver in this pair. Almost every year, that’s the case. It does stay very structurally supported. Pullbacks continue to be temporary and a value that traders can look for. Volatility, of course, will increase right around policy meetings, but again, that’s nothing new.

In 2025, the pair has been driven almost entirely by yield differentials and the Bank of Japan’s reluctance to normalize its policy. Heading into 2026, I think the structural imbalance remains intact, thereby continuing more of the same.

Levels to Watch

A couple of the levels that I am watching from a technical analysis standpoint would be the 158 yen level. If we can break above there, it opens up 160, possibly even 162. Short-term pullbacks, I think, are very likely, but when you look at the last couple of years, we have formed a massive W pattern. Now all we need is something to kick this thing off to the upside.

Another level that I’ll be watching closely is the 153 yen level, because if we break down below there, we may go back to the 150 yen level, which, as I mentioned previously, has acted like a magnet. I would be very interested in buying the dollar down there. It’s almost like getting a redo of the last three or four months.

At this point, I suspect the base case scenario for this is bullish, and traders will continue to look at every short-term pullback as a potential buying opportunity in what I think is one of the easiest pairs to hold on to, especially as you get paid at the end of every session to do so.

For a look at all of today’s economic events, check out our economic calendar.

Source link

3 01, 2026

Is There a Best Time To Take Vitamin B12?

By |2026-01-03T21:23:09+02:00January 3, 2026|Dietary Supplements News, News|0 Comments


Vitamin B12 is an essential nutrient that supports red blood cell production, nerve function, energy metabolism, and DNA synthesis. A supplement can help fill gaps when you’re not getting enough vitamin B12 from foods like eggs, oysters, and salmon, but experts say there’s no single best time to take it.

Because vitamin B12 is water-soluble, meaning it dissolves in water, it’s often best taken on an empty stomach with water, said Megan Meyer, PhD, a science communication consultant based in Durham, North Carolina. Some limited evidence also suggests vitamin B12 could reduce sleep, so taking it earlier in the day may be a good idea.

Still, there’s no universally ideal time to take vitamin B12, according to Talia Follador, RDN, LDN, a registered dietitian nutritionist and founder of Follador Nutrition Services. “What matters most is being consistent and taking the proper dosage,” she said.

While the timing of vitamin B12 may not matter much, other factors can impact the efficacy of the supplement, said Julie Pace, RDN, a functional dietitian nutritionist & founder of Core Nutrition Health & Wellness.

These include the form of the supplement, stomach acid levels, existing B12 status, and the body’s ability to produce a protein called intrinsic factor, which is essential for absorption. “Think of it as a ‘shuttle bus’ that carries B12 through your digestive system into your bloodstream,” Pace told Health. “Without it, your body can’t absorb B12 from food, regardless of how much you eat.” 

For people who have trouble absorbing B12, higher-dose supplements or even injections may be necessary, Follador said.

Meyer recommends getting vitamin B12 from food whenever possible. Many animal products naturally contain B12, and some foods—such as breakfast cereals, nutritional yeast, and plant-based milks—are fortified with it.

However, people who are deficient in vitamin B12, which can be confirmed with a blood test, may benefit from supplements. Those who follow vegan or vegetarian diets, as well as people with conditions that impair nutrient absorption, such as celiac disease or Crohn’s disease, are more likely to be deficient, Meyer said.

Supplement doses can be as high as 1,000 micrograms—far above the 2.4 micrograms most adults need—but because vitamin B12 is water-soluble and not stored in the body, these amounts are considered safe, Meyer added.



Source link

3 01, 2026

XRP Price Prediction: XRP Reclaims $2 as FVG Pullback Signals Consolidation Ahead of Major XRP Breakout

By |2026-01-03T21:15:40+02:00January 3, 2026|Crypto News, News|0 Comments

XRP has returned above the closely watched $2 mark, a level that has repeatedly acted as a long-term barrier for the token over the past several years.

The move has drawn renewed attention to the XRP price today, not only because of the psychological importance of the level but also due to a technical structure suggesting that the current rally may pause before the next decisive move. Market data, technical patterns, and on-chain trends are now aligning to frame a more nuanced XRP price prediction, one that balances short-term caution with longer-term structural strength.

XRP Price Today Holds Above $2 as Market Structure Tightens

At the time of writing, the current XRP price is hovering around $2.01, reflecting a modest daily gain and placing the token firmly back above the $2 threshold. This recovery has occurred within an ascending triangle pattern on the four-hour chart, characterized by rising lows and flat resistance near $2.12. Such formations typically signal compression in price action, where volatility contracts before a breakout or breakdown.

XRP was holding above $2, up 5.22% in the last 24 hours at press time. Source: XRP price via Brave New Coin

The price of XRP has traded within a relatively narrow intraday range between roughly $2.00 and $2.04, suggesting that traders are waiting for confirmation rather than chasing momentum. While short-term price action remains cautious, the broader setup indicates that XRP is no longer in free fall and is instead transitioning into a more balanced consolidation phase.

Technical Outlook Points to FVG Pullback Before Consolidation

From a technical standpoint, analysts are closely watching a Fair Value Gap (FVG) zone between $1.75 and $1.80. This area represents an unfilled liquidity region created during prior impulsive moves. A controlled retracement into this zone would not necessarily weaken the broader structure. Instead, it could serve as a reset, allowing leveraged positions to unwind and spot demand to re-enter at more stable levels.

XRP Price Prediction: XRP Reclaims  as FVG Pullback Signals Consolidation Ahead of Major XRP Breakout

XRP trades near $2.02 in a 4H ascending triangle, eyeing a short-term pullback to $1.75–$1.80 before a potential breakout. Source: officialjackofalltrades on TradingView

Market participants tracking the XRP price chart note that immediate support lies around $1.88–$1.91, while the FVG zone below remains a deeper area of interest. Resistance, meanwhile, continues to cap upside near $2.12, with a confirmed break potentially opening the door to higher targets in the $2.20–$2.50 range. Until that occurs, the technical bias remains neutral, with short-term downside risk balanced by longer-term breakout potential.

Long-Term Holders Accumulate as Exchange Balances Fall

On-chain data adds another layer to the evolving XRP crypto price narrative. According to metrics shared by market analysts referencing data from Glassnode, XRP balances held on centralized exchanges have dropped to their lowest level in roughly eight years. Estimates place exchange-held supply near 1.5 billion tokens, marking a decline of more than 50% since late 2025.

Long-Term Holders Accumulate as Exchange Balances Fall

XRP exchange balances have fallen to an 8-year low of 1.5 billion tokens, down 57% since October 2025, as holders move coins to cold storage, easing sell pressure. Source: @TheCryptoSquire via X

Commenting on this trend, crypto analyst John Squire noted that “coins are leaving exchanges, not rushing in,” adding that reduced exchange balances often reflect longer-term holding behavior rather than panic selling. Historically, similar conditions have preceded periods of price expansion, though such moves have not always been immediate. For the XRP value outlook, this shift suggests declining near-term sell pressure, even as escrow releases continue in the background.

Market Commentary Highlights Cautious Optimism

Despite lingering bearish sentiment in some corners of the market, several traders view the current range as constructive. Analyst Hardy, known online as Degen_Hardy, recently described the $1.80–$2.00 zone as a technically solid accumulation area. He framed the broader downtrend since mid-2025 as an opportunity for dollar-cost averaging, emphasizing a multi-year horizon rather than short-term price swings.

Market Commentary Highlights Cautious Optimism

DegenHardy frames XRP’s multi-month downtrend since July 2025 as a buying opportunity, recommending dollar-cost averaging between $1.80–$2.00 for a two-year hold. Source: @Degen_Hardy via X

This perspective gained traction after XRP rebounded sharply back above $2, validating the idea that demand remains active near established support. While such commentary does not guarantee future performance, it reflects a shift in tone from outright pessimism toward measured, longer-term positioning.

Near-Term Risk and Structural Strength

Looking ahead, the XRP price prediction remains closely tied to how the price behaves around the FVG zone and the $2.12 resistance level. A pullback followed by sustained consolidation would reinforce the view that XRP is building a base rather than rolling over. Conversely, a clean break above resistance could confirm the ascending triangle breakout and shift momentum decisively higher.

For now, the XRP market cap, which stands above $120 billion, reflects both renewed interest and ongoing uncertainty. With ETF inflows, declining exchange balances, and continued development on the XRP Ledger, the market appears to be laying groundwork rather than chasing speculative extremes. As 2026 approaches and regulatory clarity remains in focus, particularly around the broader XRP SEC narrative, XRP’s next major move is likely to emerge from this period of consolidation rather than from abrupt volatility.

In that context, XRP reclaiming $2 may prove less about immediate upside and more about re-establishing structural credibility- an essential step before any sustained breakout can take shape.

Source link

Go to Top